Delphinus Medical Technologies
Novi, US · Founded 2010 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
SW
Scott WhiteExecutive Officer, Director
EB
Elise BermanExecutive Officer
PM
Paul McCreadieDirector
CS
Chris SandersExecutive Officer
HR
Heather RoneExecutive Officer
ND
Neb Duric, Ph.D.Executive Officer
DS
Debra SaundersExecutive Officer
SO
Shawn O'BrienExecutive Officer
HB
Hugo BraunDirector
JN
John NeisDirector
MF
Michael FultonDirector
RH
Ronald HoDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$27.6MraisedApr 2025 · 8 investors · BiotechnologyRule 506(b)
▶$27.6MraisedApr 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hugo BraunDirector
- John NeisDirector
- Michael FultonDirector
- Ronald HoDirector
- Rachel BremDirector
- Scott WhiteExecutive Officer, Director
- Mark ForchetteDirector
- Elise BermanExecutive Officer
- Michael GrossDirector
- Offering amount
- $27.6M
- Amount sold
- $27.6M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedJun 2023 · 9 investors · BiotechnologyRule 506(b)
▶$5MraisedJun 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael FultonDirector
- Mark ForchetteExecutive Officer, Director
- Michael GrossDirector
- Shawn O'BrienExecutive Officer
- Paul McCreadieDirector
- Heather RoneExecutive Officer
- Rachel BremDirector
- Ronald HoDirector
- Neb DuricExecutive Officer
- John NeisDirector
- Hugo BraunDirector
- Olivier RoyExecutive Officer
- Offering amount
- $8M
- Amount sold
- $5M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.4MraisedSep 2022 · 10 investors · BiotechnologyRule 506(b)
▶$30.4MraisedSep 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Neb DuricExecutive Officer
- Shawn O'BrienExecutive Officer
- Rachel BremDirector
- Hugo BraunDirector
- Heather RoneExecutive Officer
- Olivier RoyExecutive Officer
- Michael GrossDirector
- Paul McCreadieDirector
- Ronald HoDirector
- Michael FultonDirector
- Mark ForchetteExecutive Officer, Director
- John NeisDirector
- Offering amount
- $30.4M
- Amount sold
- $30.4M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.2MraisedApr 2017 · 9 investors · BiotechnologyRule 506(b)
▶$8.2MraisedApr 2017 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John NeisDirector
- Heather RoneExecutive Officer
- Paul McCreadieDirector
- Debra SaundersExecutive Officer
- Michael FultonDirector
- Michael GrossDirector
- Neb DuricExecutive Officer
- Ronald HoDirector
- Mark ForchetteExecutive Officer, Director
- Francis DobschaExecutive Officer
- Shawn O'BrienExecutive Officer
- Hugo BraunDirector
- Offering amount
- $25M
- Amount sold
- $8.2M
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$39.5MraisedSep 2015 · 10 investors · BiotechnologyRule 506(b)
▶$39.5MraisedSep 2015 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael GrossDirector
- Hugo BraunDirector
- Paul McCreadieDirector
- Chris SandersExecutive Officer
- John NeisDirector
- Heather RoneExecutive Officer
- Ronald HoDirector
- Michael FultonDirector
- Neb Duric, Ph.D.Executive Officer
- Debra SaundersExecutive Officer
- Mark J. ForchetteExecutive Officer, Director
- Shawn O'BrienExecutive Officer
- Offering amount
- $45M
- Amount sold
- $39.5M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.